IP Verse

Glaxosmithkline vs. Moderna - ACT_32173/2025

The UPC Case ACT_32173/2025 was filed on 04 Jul, 2025 by the plaintiff Glaxosmithkline, Glaxosmithkline against the defendant Moderna, Moderna, Moderna, and others.

Case Details

    Case Number:

    ACT_32173/2025

    Patent Number:

    EP4066856, EP4226941

    Filing Date:

    04 Jul, 2025

    Proceeding Type:

    Proceeding

    Action/Application:

    Infringement Action

    Plaintiffs:

    • Glaxosmithkline Biologicals
    • Glaxosmithkline Biologicals Sa

    Plaintiff Representatives:

    • Tjibbe Douma

    Defendants:

    • Moderna
    • Moderna Belgium
    • Moderna Belgium S.R.L.
    • Moderna Biotech Distributor UK
    • Moderna Biotech Spain
    • Moderna Biotech UK
    • Moderna Biotech Uk Limited
    • Moderna France Sasu
    • Moderna Germany
    • Moderna Germany Gmbh
    • Moderna Italy
    • Moderna Italy S.R.L.
    • Moderna Netherlands
    • Moderna Netherlands B.V.
    • Moderna Norway
    • Moderna Norway As
    • Moderna Poland Sp. Z.O.O.
    • Moderna Poland SP ZOO
    • Moderna Portugal Unipessoal Lda
    • Moderna Portugal Unipessoal LDA
    • Moderna Sweden
    • Moderna Sweden AB
    • Moderna Switzerland
    • Moderna Switzerland Gmbh
    • Modernatx
    • Modernatx, Inc.

    Defendant Representatives:

    • Matthew Naylor
    • Thomas WOLTER

    Judges:

    • Edger Brinkman
    • Margot Kokke
    • Stefan Schilling

    Court Division:

    First Instance, Local Division - The Hague

Case Decision

Decision pending - set alert to receive updates

Docket Entries

No docket found - set alert to stay updated on new entries.

More cases involving EP4066856B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_619/2025Jul 4, 2025GlaxosmithklineModerna
ACT_32285/2025Jul 3, 2025GlaxosmithklineBiontech, Biontech Europe, Biontech Manufacturing, Biontech Manufacturing Marburg, CP Pharmaceuticals CV, Laboratorios Pfizer, Pfizer, Pfizer AB, Pfizer Austria Gesellschaft, Pfizer Croatia DOO, Pfizer Export, Pfizer Gyogyszerkereskedelmi KFT, Pfizer Hellas AE, Pfizer Luxembourg, Pfizer Manufacturing Belgium, Pfizer Pharma, Pfizer Polska SP ZOO, Pfizer Romania, Pfizer Sanv, Pfizer Service Bvsrl, Pfizer Trading Polska SP ZOO
UPC_CFI_621/2025Jul 3, 2025GlaxosmithklineBiontech, Biontech Europe, Biontech Manufacturing, Biontech Manufacturing Marburg, CP Pharmaceuticals CV, Laboratorios Pfizer, Pfizer, Pfizer AB, Pfizer Austria Gesellschaft, Pfizer Croatia DOO, Pfizer Export, Pfizer Gyogyszerkereskedelmi KFT, Pfizer Hellas AE, Pfizer Luxembourg, Pfizer Manufacturing Belgium, Pfizer Pharma, Pfizer Polska SP ZOO, Pfizer Romania, Pfizer Sanv, Pfizer Service Bvsrl, Pfizer Trading Polska SP ZOO

More cases involving Glaxosmithkline

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_33242/2025Jul 21, 2025Glaxosmithkline -
App_33256/2025Jul 21, 2025Glaxosmithkline -
App_33285/2025Jul 21, 2025Glaxosmithkline -

More cases involving Moderna

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34390/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
ORD_34391/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
App_33094/2025Jul 17, 2025Moderna -